MBX Biosciences Announces Executive Leadership Transition To Support The Company’s Next Phase Of Growth
MBX•Executive leadership transition
July 13 (Reuters) - MBX Biosciences Inc MBX.O:
- MBX Biosciences announces executive leadership transition to support the company’s next phase of growth
- MBX Biosciences appoints Steve Hoerter as chairman and CEO
- MBX Biosciences says Kent Hawryluk steps down as president, CEO and board member
- MBX Biosciences appoints John Smither as chief financial officer
- MBX Biosciences says all leadership changes are effective immediately
